PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 1, 1989Hypertension152 citations

Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence.

View Full Paper
PWPaul K. WheltonMKM J Klag

Key Result

Mild hypertension increases the risk of subsequent renal disease, with the risk of blood pressure-related end-stage renal disease appearing especially high in Black patients.

Key Points

  • To investigate the relationship between hypertension and the risk of developing renal disease, especially in patients with mild hypertension.
  • Analyzed findings from randomized controlled trials of antihypertensive therapy.
  • Reviewed data from the Hypertension Detection and Follow-up Program and Medicare ESRD Program.
  • Discussed observational studies including death certificate and insurance data.
  • Mild hypertension may increase the risk of renal disease, particularly in black populations.
  • Evidence from major programs indicates a heightened risk of ESRD related to hypertension in certain demographics.
  • Projected increase in Medicare ESRD beneficiaries due to hypertensive conditions over the next 30-40 years.

Structured PICO

Does mild hypertension increase the risk of subsequent renal disease, and does antihypertensive therapy prevent it?

P
Population
Patients with hypertension, particularly milder forms
I
Intervention
Antihypertensive therapy
O
Outcome
Renal disease and End-Stage Renal Disease (ESRD)hard clinical

This review highlights that mild hypertension is likely a risk factor for end-stage renal disease, particularly in black patients, though further confirmatory studies are needed.

Limitations

  • Results need to be confirmed by additional studies
  • Observational studies provide little information
  • Randomized controlled trials provide equivocal results
  • Results need to be confirmed

Abstract

Renal failure is a well-recognized complication of accelerated and malignant hypertension that can be prevented by appropriate antihypertensive therapy. The risk of renal disease in patients with milder forms of hypertension is less certain. Death certificate, insurance industry, and community-based observational studies provide little information with respect to the risk of kidney damage in the hypertensive patient. Randomized controlled trials of antihypertensive drug therapy provide equivocal results. The strongest evidence in support of the hypothesis that mild hypertension increases the risk of subsequent renal disease comes from analyses of the Hypertension Detection and Follow-up Program and the Medicare End-Stage Renal Disease (ESRD) Program. The risk of blood pressure-related ESRD appears to be especially high in blacks, independent of age, sex, and prevalence of hypertension. Although these results need to be confirmed, the data raise the possibility that the effects of high blood pressure on the kidney are different in blacks than in whites. Based on current trends, it is projected that the number of beneficiaries in the Medicare ESRD Program will continue to increase during the next 30-40 years and that the diagnosis of hypertensive ESRD will become increasingly common. Additional studies to characterize the relation between mild hypertension and subsequent risk of renal disease and to confirm the corresponding benefits of antihypertensive therapy are urgently needed.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Whelton et al. (1989) conducted a review in Hypertension and renal disease. Hypertension was evaluated on Renal disease and End-Stage Renal Disease (ESRD). Mild hypertension increases the risk of subsequent renal disease, with the risk of blood pressure-related end-stage renal disease appearing especially high in Black patients.

synapsesocial.com/papers/6a09834830285ee4a134064bhttps://doi.org/10.1161/01.hyp.13.5_suppl.i19
Ask AI
Helpful
Bookmark
Share
View Full Paper